| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | BIOTECNOLOGÍA | 2.584,460000 | 06/11/2025 | 25,68% | 36,75% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | BIOTECNOLOGÍA | 669,617619 | 06/11/2025 | 15,36% | 23,21% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | BIOTECNOLOGÍA | 399,690000 | 06/11/2025 | 16,13% | 28,13% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | BIOTECNOLOGÍA | 304,040579 | 06/11/2025 | 16,58% | 27,92% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | BIOTECNOLOGÍA | 260,860000 | 06/11/2025 | 26,49% | 39,14% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 2.316,873320 | 06/11/2025 | 15,84% | 26,10% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS C CAP EUR | RVI EMERGENTES | 1.225,180000 | 06/11/2025 | 20,93% | 38,18% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS C DIS EUR | RVI EMERGENTES | 757,730000 | 06/11/2025 | 17,95% | 28,07% | ** |
| CANDRIAM EQUITIES L EMERGING MARKETS C-H CAP USD | RVI EMERGENTES | 229,558658 | 06/11/2025 | 10,68% | 24,93% | ** |
| CANDRIAM EQUITIES L EMERGING MARKETS I CAP EUR | RVI EMERGENTES | 1.480,850000 | 06/11/2025 | 21,72% | 42,68% | **** |
